Analysts Expect Healthways, Inc. (TVTY) Will Announce Earnings of $0.36 Per Share

Brokerages expect that Healthways, Inc. (NASDAQ:TVTY) will announce earnings per share (EPS) of $0.36 for the current quarter, according to Zacks. Five analysts have made estimates for Healthways’ earnings, with the lowest EPS estimate coming in at $0.35 and the highest estimate coming in at $0.37. Healthways posted earnings of $0.30 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 20%. The firm is scheduled to issue its next earnings report on Tuesday, November 7th.

According to Zacks, analysts expect that Healthways will report full year earnings of $1.53 per share for the current financial year, with EPS estimates ranging from $1.51 to $1.56. For the next year, analysts expect that the company will report earnings of $1.66 per share, with EPS estimates ranging from $1.59 to $1.74. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that cover Healthways.

Healthways (NASDAQ:TVTY) last posted its earnings results on Thursday, July 27th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.03. Healthways had a net margin of 17.30% and a return on equity of 29.81%. The company had revenue of $138.90 million during the quarter, compared to analysts’ expectations of $138.15 million. The business’s quarterly revenue was up 11.1% on a year-over-year basis.

A number of brokerages recently issued reports on TVTY. Chardan Capital began coverage on Healthways in a research note on Tuesday. They set a “neutral” rating and a $40.00 price objective for the company. ValuEngine upgraded Healthways from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Zacks Investment Research downgraded Healthways from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. Jefferies Group LLC restated a “buy” rating and issued a $36.00 price target on shares of Healthways in a research note on Friday, June 16th. Finally, Cantor Fitzgerald upped their price target on Healthways from $34.00 to $42.00 and gave the stock an “overweight” rating in a research note on Friday, June 9th. Two investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $39.88.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://stocknewstimes.com/2017/09/13/analysts-expect-healthways-inc-tvty-will-announce-earnings-of-0-36-per-share.html.

Shares of Healthways (NASDAQ:TVTY) traded up 0.67% during mid-day trading on Tuesday, reaching $37.80. 475,617 shares of the company’s stock traded hands. Healthways has a 12-month low of $19.25 and a 12-month high of $41.55. The company has a market cap of $1.49 billion, a P/E ratio of 17.03 and a beta of 0.37. The firm has a 50-day moving average of $38.66 and a 200 day moving average of $33.41.

In other news, insider Glenn Hargreaves sold 23,448 shares of the company’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $37.78, for a total transaction of $885,865.44. Following the sale, the insider now directly owns 62,211 shares of the company’s stock, valued at approximately $2,350,331.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Conan Laughlin sold 1,750,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $37.90, for a total value of $66,325,000.00. The disclosure for this sale can be found here. Insiders sold a total of 1,809,913 shares of company stock valued at $68,582,025 over the last 90 days. 8.42% of the stock is currently owned by corporate insiders.

Several hedge funds have recently modified their holdings of TVTY. State of Alaska Department of Revenue purchased a new stake in shares of Healthways during the first quarter valued at about $107,000. Flinton Capital Management LLC boosted its stake in shares of Healthways by 63.5% in the second quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock valued at $139,000 after buying an additional 1,360 shares during the period. ClariVest Asset Management LLC purchased a new stake in shares of Healthways during the first quarter valued at about $141,000. Riverhead Capital Management LLC boosted its stake in shares of Healthways by 69.7% in the second quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock valued at $142,000 after buying an additional 1,464 shares during the period. Finally, US Bancorp DE purchased a new stake in shares of Healthways during the first quarter valued at about $145,000.

About Healthways

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Get a free copy of the Zacks research report on Healthways (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthways (NASDAQ:TVTY)

Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply